Thyrotoxic periodic paralysis: a short clinical review

Authors

  • Rashmi Aggarwal Department of Thyroid and Endocrine Research Health Centre, Institute of Nuclear Medicine and Allied Sciences (INMAS), Timarpur, Delhi
  • Pradeep Chugh Department of Thyroid and Endocrine Research Health Centre, Institute of Nuclear Medicine and Allied Sciences (INMAS), Timarpur, Delhi

Keywords:

Thyrotoxic periodic paralysis (TPP), Hypokalemia, Potassium, Propranolol

Abstract

Thyrotoxic Periodic Paralysis (TPP) is a potentially lethal manifestation of hyperthyroidism which is characterized by hypokalemia and muscular weakness. It mainly affects Asian men in the age group of 20 to 40 years. Immediate supplementation with oral or intravenous potassium will help to not only abort the acute attack of paralysis but will also prevent serious and life threatening cardiac arrhythmias. Non selective beta blockers like propranolol can also be used to ameliorate and prevent subsequent paralytic attack. Acetazolamide has no role in the treatment of TPP.

References

Okinaka S, Shizume K, Lino S, Watanabe A, Irie M, Noguchi A, et al. The association of periodic paralysis and hyperthyroidism in Japan. J Clin Endolcrinol Metab. 1957;17:1454-9.

Ober KP. Thyrotoxic periodic paralysis in the United States. Reports of 7 cases and review of literature. Medicine. 1992;71:109-20.

Wong GW, Leung TF, Lo AF, Ahuja AT, Cheng PS. Thyrotoxic periodic paralysis in a 14-year old boy. Eur J Pediatr. 2000;159:934.

Ahlawat SK, Sachdeva A. Hypokalemic paralysis. Postgrad Med J. 1999;75:193-7.

Talbott JH. Periodic paralysis. Medicine. 1941;20:85-102.

Maurya PK, Kalita J, Misra UK. Spectrum of hypokalemic periodic paralysis in a tertiary care centre in India. Postgrad Med J. 2010;86:692-5.

Chan A, Shinde R, Chow CC, Cockram CS, Swaminathan R. In vivo and in vitro sodium pump activity in subjects with thyrotoxic periodic paralysis. Br Med J. 1991;303:1096-9.

Aggarwal S, Nand N, Aggarwal HK. Thyrotoxic periodic paralysis. J Indian Acad Clin Med. 2007;8:265-7.

Guerra M, Rodriguez del Castillo A, Battaner E, Mas M. Androgens stimulate preoptic area Na+, K+-ATPase activity in male rats. Neurosci Letters. 1987;78:97-100.

Kung AW. Clinical review: thyrotoxic periodic paralysis: a diagnostic challenge. J Clin Endocrinol Metab. 2006;91:2490-5.

Kelley DE, Gharib H, Kennedy FP, Duda RJ Jr, McManis PG. Thyrotoxic periodic paralysis. Report of 10 cases and review of electromyographic findings. Arch Intern Med. 1989;149:2597-600.

Lu KC, Hsu YJ, Chiu JS, Hsu YD, Lin SH. Effects of potassium supplementation on the recovery of thyrotoxic periodic paralysis. Am J Emerg Med. 2004;22:54454-7.

Lin SH, Lin YF. Propranolol rapidly reverses paralysis, hypokalemia, and hypophosphatemia in thyrotoxic periodic paralysis. Am J Kidney Dis. 2001;37:620-3.

Vijaykumar A, Ashwath G, Thimmappa D. Thyrotoxic periodic paralysis: clinical challenges. J Thyroid Res. 2014;2014:649502.

Pooja Pothivala, Steven N. Levine. Analytic review: thyrotoxic periodic paralysis: a review. J Intensive Care Med. 2010;25:71-7.

Downloads

Published

2017-01-07

How to Cite

Aggarwal, R., & Chugh, P. (2017). Thyrotoxic periodic paralysis: a short clinical review. International Journal of Research in Medical Sciences, 3(3), 539–542. Retrieved from https://www.msjonline.org/index.php/ijrms/article/view/1326

Issue

Section

Review Articles